Gyoutoku, N., Inoguchi, Y., Rikitake, J., Demiya, M., Gobaru, M., Nagayama, A., Iwata, S., Hasuzawa, N., Nakayama, H., Ashida, K., Nomura, M. (2025). Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes. PLoS ONE. https://doi.org/10.1371/journal.pone.0335888